Gingivocrevicular transudate for HIV screening
Abstract
Producción Científica
Full text
588
Clinical Mic obiology and In ec ion, Volume
3
Numbe
5,
Oc obe 1997
ha he co ec ional acili ies, which
a
p esen ha e
inadequa e in ec ion con ol p ac ices and isola ion
acili ies o p e en ansmission o
M. ube culosis,
ully
comply wi h he cu en guidelines
o
educe he isk
o ube culosis sp ead
[14,15].
Acknowledgmen s
This wo k was pa ly suppo ed by he Comisi6n
In e minis e ial de Ciencia y Tecnologia (CICYT)
g an SAF95/0435 by he Minis e io de Educaci6n y
Ciencia.
Jauie Azna
I,
Hassan
S&*,
Mada C. Conejo’,
Jos6
C. Paloma es’
‘Dp o Mic obiologia, Apdo 914,
Uni e sidad de Se illa,
41080-Se illa, Spain;
*Depa men o Mic obiology,
Uni e si y o Se ille,
Se ille, Spain
Re ised e sion accep ed
3
May
1997
Re e ences
1.
G ei inge
RB,
Kee us C, G abau
J,
e al. T ansmission
o mul id ug- esis an ube culosis among immunocom-
p omised pe sons in a co ec ional sys em. New Yo k
1991.
2.
Sepkowi z KA, R&ah J, Riley L, Kiehn TE, Ams ong
D.
Tube culosis in he AIDS e a. Clin Mic obiol Re
1995; 8:
MMWR
1992; 41: 507-9.
180-99.
3.
Valway SE, Richa ds SB, Ko aco ich J, G ei inge
RB,
C aw o d JT, Dooley SW. Ou b eak o mul i-d ug- esis an
ube culosis in
a
New Yo k S a e P ison
1991.
Am J
Epidemiol
1994; 140: 113-22.
4.
De Ma ch
P.
Si uaci6n ac ual
de
la ube culosis en Espaiia.
Med Clin (Ba c)
1991; 97: 463-72.
5.
Ma in V, Gonzalez
P,
Cayla JA, e
al.
Case- inding o
pulmona y ube culosis on admission o
a
peni en ia y cen e.
Tube cle Lung Dis
1994; 75: 49-53.
6.
He mans PWM, an Soolingen D, Dale JW, e
al.
Inse ion
elemen
IS986
om
Mycobac e ium ube culosis:
a use ul
ool o diagnosis and epidemiology o ube culosis.
J
Clin
Mic obiol
1990; 28: 2051-8.
7.
Small PM, Sha e RW, Hopewell PC, e al. Exogenous
ein ec ion wi h mul id ug- esis an
Mycobac e ium ube culosis
in pa ien s wi h ad anced
HIV
in ec ion. N Engl
J
Med
8.
an Soolingen
D,
He mans PW, de Haas PEW,
Soll
DR,
an Embden JDA. Occu ence and s abili y o inse ion
sequences in
Mycobac e ium ube culosis
complex s ains:
e alua ion o an inse ion sequence-dependen DNA poly-
mo phism
as
a
ool in he epidemiology
o
ube culosis.
J Clin Mic obiol
1991; 29: 2578-86.
9.
Kubica GPW, Dye E, Cohn ML, Middleb ook DH. Spu um
diges ion and decon amina ion wi h N-ace yl-L-cys eine-
1993; 328: 1137-44.
sodium hyd oxide o cul u e o mycobac e ia. Am Re
Respi Dis
1963; 87: 775-9.
10.
an Embden JDA, Donald Ca e M, C aw o dJT, e al. S ain
iden i ica ion o
Mycobac e ium ube culosis
by DNA inge -
p in ing: ecommenda ions o
a
s anda hzed me hodology.
J Clin Mic obiol
1993; 31(2): 406-9.
11.
Azna J, Sa i
H,
Rome o
J,
Alejo A, G acia
MD,
Paloma es
JC. Nosocomial ansmission o ube culosis in ec ion in
pedia ic wa ds. Peha In ec Dis
J
1995; 14: 44-8.
12.
He mans PWM, Messadi
F,
Gueb exabbe H, e al. Analysis
o he popula ion s uc u e o
Mycobac e ium ube culosis
in E hiopia, Tunisia, and he Ne he lands: use ulness o
DNA yping o global ube culosis epidemiology.
J
In ec
Dis
1995; 171: 1504-13.
13.
Ba nes PE El-Haj H, P es on-Ma in
S,
e al. T ansmission
o ube culosis among he u ban homeless. JAMA
1996; 275:
14.
The ole o BCG accine in he p e en ion and con ol
o ube culosis in he Uni ed S a es. A join s a emen by
he Ad iso y Commi ee o Elimina ion o Tube culosis
and he Ad iso y Commi ee on Immuniza ion P ac ices.
15.
P e en ion and con ol o ube culosis in co ec ional
acili ies. Recommenda ions o he elimina ion o ube -
culosis. MMWR
1996; 45: 1-27.
305-7.
MMWR
1996; 45: 1-14.
Gingi oc e icula ansuda e o
HIV
sc eening
Clin Mic obiol
In ec
1997;
3:
588-590
The use o sali a
as
an al e na i e biological luid o
se um in diagnosis o sc eening o in ec ious diseases by
an ibody de ec ion has been he main subjec o se e al
a icles in he las ew yea s [l-61. Sah a samples can be
ob ained simply, wi hou specialized pe sonnel, and he
p ocess is non- auma ic o he pa ien and economic
and poses no con amina ion isks o heal h wo ke s.
Fo hese easons, sali a samples may be o g ea u ili y
in unde de eloped na ions, whe e he e is
a
se e e
sho age o pe sonnel and specialized equipmen . Sali a
is
a
mix u e o he sec e ions p oduced by he sali a y
glands and gingi al c e icula ansuda e (GCT). The
use o GCT, which has
a
g ea e concen a ion o
immunoglobulins (Ig) o he IgG ype han does
comple e sali a [7], seems o imp o e de ec ion o such
Ig in he samples
[8].
An o al de ice wi hou p ese a i es (Sali e e,
S a s ed , Leices e ,
UK)
was used o ob ain he GCT
samples. The de ice
is
a
cylinde o co on wool con-
ained in a polys y ene double ube wi h a snap op
(p ice USA
$0.20).
The co on wool was placed in he
la e al gingi al old un il he indi idual could pe cei e
ha i had become
so
because
o
i s abso p ion o
GCT. The samples hus ob ained we e cen i uged a
4000
g
o
15
min, p oducing
a
supe na an which was
Sho Communica ions and Le e s
o
he Edi o s
589
aliquo ed and ozen
a
-80°C un il p ocessing. A
se um sample was simul aneously ob ained by ene-
punc u e om each o he indi iduals included in he
s udy. These samples we e hen aliquo ed and s o ed
a
-80°C un il p ocessed.
A
o al o
183
pai ed samples o GCT and se um
we e analyzed
(50
CDC s age
11,
10
CDC s age 111,
33
CDC s age
I
26 isk ac o indi iduals and 64 blood
dono s). In bo h ypes o sample, he p esence
o
IgG
agains HIV-I and HIV-2 was de ec ed. Wi h GCT
samples, we used
a
new do blo (Mul ispo HIV-
1 /HIV-2, Sano i Diagnos ics Pas eu , F ance) capable
o disc imina ing be ween bo h IgG HIV-1 and IgG
HIV-2. Fo he sc eening o se um samples, an indi ec
enzyme immunoassay (EIA) (VIDAS HIV 1+2,
bioMk ieux, F ance) was used. All eac i e samples
we e con i med by Wes e n blo
(WB)
(Bioblo HIV-
I
plus, Genelabs Diagnos ics, Swi ze land). The
WB
used combines speci ic p o eins o HIV-1 and
a
syn he ic pep ide (gp36) o HIV-2 in he same s ip;
WHO
c i e ia
[9]
we e used o con i ma ion o
sc eening eac i i y.
The esul s p esen ed in Table 1 show ha
all
GCT
samples non- eac i e by do blo belonged
o
non-
in ec ed indi iduals (EIA nega i e), excep o one
sample om
a
pa ien o he CDC s age IV g oup,
which was nega i e by do blo bu posi i e by GCT
WB ( eac i i y agains
gp160,
gp120 and gp41). The
GCT samples eac i e by do blo co espond
o
in ec ed indi iduals, wi h he excep ion o one sample
om
a
non-in ec ed indi idual also nega i e by GCT
WB. The cha ac e is ics o his es in compa ison wi h
se um WB esul s ha e been as ollows:
99%
sensi i i y
and
99%
speci ici y (posi i e p edic i e alue (PPV) and
nega i e p edic i e alue (NPV) we e
0.9).
Se e al easons may be sugges ed in he case o he
non- eac i e sample om he indi idual belonging o
CDC s age IV The i s is he immunologic de e io a-
ion p esen ed by indi iduals in he inal s ages
o
he
in ec ion, yielding
a
lowe IgG se um concen a ion
and e en loss o conc e e an ibodies (ie. p24 an i-
bodies); second, GCT may he e o e no p esen
eac i i y when analyzed by insu icien ly sensi i e
echniques. The use o
a
mo e sensi i e es (WB) leads
in his case o he de ec ion
o
IgG agains en elope
p o eins in he GCT. The con i med p esence o HIV-
1
en elope an ibody in GCT
is
highly sugges i e o
HIV-1 in ec ion and also co ela es wi h he eac i i ies
ob ained in he se um
WB
o his indi idual.
The sali a y de ice used p esen s
wo
main
ad an ages. The i s and mos impo an
is
ha i can
ob ain an adequa e olume
(=
1
ml)
o sample analysis
by di e en echniques and s o age. Second, in con as
o he case wi h o he de ices, IgG sample concen-
a ion does no a y
so
much, because he sample
is
no dilu ed. The e is no expe imen al e idence ha he
concen a ion o Ig in GCT declines du ing s o age,
bu any such changes would be minimal, because he
samples we e no dilu ed in any p ese a i e bu e and
hey we e ozen a e eco e y, hus minimizing he
ac ion o sali a enzymes. GCT samples (USA $0.20) a e
cheape o ob ain han se um samples (USA
$0.60
o
sy inge +needle+ ube). Fu he mo e, he GCT p o-
cess pe mi s a single indi idual o collec samples om
se e al pa ien s
a
once, ins ead o he indi idualized
sample collec ion equi ed wi h se um.
Ou esul s con i m p e ious wo k by o he s
[10,11] bu using
a
simple de ice o sampling and
es ing. The use o GCT ins ead o sali a has been
p oposed in se e al a icles [8,10,11] o acili a e he
de ec ion o HIV IgG due o he inc eased amoun o
his ype o
Ig.
In conclusion, he use o do blo oge he wi h
he o al GCT de ice could o e an al e na i e o
sc eening o in ec ion p oduced by HIV
in
wide
popula ion g oups, because o i s low cos and easy
applica ion. Fu he s udies should be pe o med in
pa ien s wi h ad anced s ages o he disease o de e -
mine i he lloss in sensi i i y could be due o he
immunologic condi ion in his pa icula s age o he
disease.
Table
1
De ec ion
o
HIV-1
an ibodies
in
he se um
and
GCT
o
di e en popula ion
g oups
G oup
No.
Do cc EIAsc unl mp"
S age
I1
50
50 50 50
S age
I11
10 10 10
10
S age IV
33
32
33
33
Subjec s
a
isk
o
HIV in ec ion 26
0 0
0
Blood dono s
64
lb 0
0
Re e ences
P udencio Ma inez,
josk
Ma ia
Ei os
Raul
O iz
dc
Leja a u
An onio
Rod kuez
To es
Se icio de Mic obiologia Clinica,
Hospi al Uni e si a io, Valladolid, Spain
Accep ed
25
Ap il
1997
To al
183
93
93
93
1.
Pa
IV.
Pe m
KR.
Mo ime
PP.
Sensi i e
assa s
o i al
,_l,
,
,
an ibodies in sali a:
an
al e na i e o
ec
011
ce um. Lance
"Samples wi h posi i e Wes e n blo in se um and
GCT.
"Sample wi h nega i e Wes e n
blo
in GCT.
1987;
2:
72-5.
590 Clinical Mic obiology and In ec ion, Volume
3
Numbe 5, Oc obe 1997
4.
5.
6.
7.
8.
9.
10.
11.
2. Pa y JV, Pe y
KR,
Panday
S,
Mo ime PP. Diagnosis o
hepa i is
A
and
B
by es ing sali a.
J
Med Vi ol 1989; 28:
255-60.
3. Thieme
T,
Yoshiha a
P,
Piacen ini
S,
Belle
M:
Clinical
e alua ion o o al luid samples o diagnosis o i al hepa i is.
J Clin Mic obiol 1992; 30: 1076-9.
Luch E, Albe J, Linde A, e al. Human ihmunode iciency
i us ype
l
and cy omegalo i us in sali a. J Med Vi ol 1993;
39.
15Gh2
The HBe Ag p ecu so
is
encoded by he 637-bp
p eco e/co e open eading ame s a ing
a
nucleo ide
1814 o he HBV minus s and genome (nomencla u e
acco ding
o
Galibe
e
al
[4]),
The equen ly
desc ibed mu a ion is
a
G
o
A
subs i u ion
a
he
3’
end o he p e-C gene (nucleo ide 1896), which
con e s codon 28 o yp ophan (TGG) o a e mina-
ion codon (TAG)
[S],
esul ing in he ailu e o HBe
-
.
.
.
-
-
..
-
.
F e ichs
R,
H oo i M, Eskes
N,
Soe
L.
Compa ison
o
sali a
and se um o HIV su eillance in de eloping coun ies.
Lance 1992; 340: 1496-9.
Akke
R,
Hoek
J,
Akke W, e
al.
De ec ion o HIV
an ibodies in sali a as
a
ool o epidemiological s udies.
Pa y
JV.
A specimen o con enience. Diagn Vi ol 1991; 3:
Ma inez
P,
O iz de Leja azu
K,
Ei os JM, e al.
Compa ison o
wo
assays o de ec ion
o
HIV an ibodm
in sali a. Eu
J
Clin Mic obiol 1995; 14: 330-6.
Wo ld Heal h O ganiza ion. AIDS. P oposed WHO c i e ia
o in e p e ing esul s
iom
Wes e n blo assays o HIV-1,
HIV-2 and HTLV-I/HTLV-11. Wkly Epidemiol Rec 1990;
G6mez C, Gu i ez
M,
Ma inez-Acacio
P,
So iano
V.
E alua ion
o
a
new sali a collec ion de ice o HIV an i-
body sc eening pu poses. Vox Sang 1994; 66: 244.
Gallo D, Geo ge
R,
Fi chen
J,
Golds ein A, Hindahl M.
E alua ion o
a
sys em using o al mucosal ansuda e o
HIV-1 an ibody sc eening and con i ma o y es ing. JAMA
1997; 277: 254-8.
AIDS 1992; 6: 953-7.
13-15.
65: 281-3.
Mo e on HBe Ag-nega i e mu an s in ch onic HBV
in ec ion
Clin
Mic obiol
In ec
1997;
3:
590-591
Ch onic in ec ion wi h hepa i is B i us (HBV) leads
o
a
wide spec um o li e diseases, including asymp-
oma ic ca ie s a e, ch onic ac i e hepa i is, ci hosis
and hepa ocellula ca cinoma. Pa ien s p esen ing wi h
ch onic ac i e hepa i is ypically ha e e idence o HBV
eplica ion ma ked by high le els o HBV DNA, HBV
su ace an igen (HBs Ag) and he e an igen (HBe Ag)
in hei se um [l]. In la e s ages o he disease,
se ocon e sion om HBe
Ag
o an i-HBe an ibody
classically indica es a ansi ion o
a
‘non- eplica i e’
phase, in which nec o-in lamma o y ac i i y ceases. In
some cases, howe e , an i-HBe se ocon e sion
is
no
ollowed by such
a
a o able ou come, and ma ke s o
HBV eplica ion emain de ec able [2]. Ca man
e
a1
[3] ha e s udied such pa ien s and ound ha hey
ca ied HBV mu an s which canno syn hesize he
p eco e p ecu so p o ein and he e o e HBe Ag.
Ag p oduc ion and he cessa ion o i s sec e ion in o
he bloods eam. I
is
o en associa ed wi h a
G
o A
silen mu a ion a nucleo ide (n ) posi ion 1899. The
equency o he n 1896 mu a ion a ies in di e en
s udies, anging om 46%
[6]
o 80% [3]. This a i-
abili y led
us
o in es iga e he equency o he n 1896
mu a ion and he p esence o o he pu a i e mu a ions
in a coho o F ench pa ien s.
We analyzed 32 se um samples om ch onically
in ec ed pa ien s showing disco dan se ologic p o iles,
i.e. posi i e o HBs Ag and HBV DNA, nega i e o
HBe Ag and posi i e o an i-HBe an ibody. Se um
samples we e submi ed o hea ea men (100
“C)
o
30 min and hen cla i ied by cen i uga ion (12000g)
o 30 min. This apid echnique o HBV DNA
p epa a ion had been alida ed in p elimina y s udies
as compa ed ei he o classical p o einase K-sodium
dodecylsul a e
(SDS)
lysis ollowed by phenol ex ac ion
o
o
NaOH ea men o he se um. We applied an
ampli ica ion-c ea ed es ic ion si e me hod de i ed
om ha desc ibed by Lindh e a1 [7] o de ec ing he
n 1896
G
o
A mu a ion. Acco ding o his p ocedu e,
he n 1865-2058 egion o HBV DNA was ampli ied
using
P1
p ime wi h
a
misma ch
a
posi ion 1893.
When he n 1896 G o A mu a ion was p esen , he
194-bp
PCR p oduc exhibi ed a BSU 361 es ic ion
si e which could be shown by enzyme diges ion and
aga ose gel elec opho esis. P io o hges ion, a plasmid
con aining
a
unique BSU 361 es ic ion si e
was
added as a con ol o he comple ion o diges ion.
The speci ici y
o
he PCR eac ion was checked by
hyb idiza ion wi h a digoxigenin-labeled p obe speci ic
o he HBV p eco e egion. In pa allel, he n
1728-2160 egion o HBV DNA was ampli ied o
he de e mina ion o nucleo ide sequence using a T7
polyme ase sequencing
ki
(Pha macia).
A e diges ion wi h BSU 361, we obse ed h ee
pa e ns o mig a ion in an aga ose gel among he 32
samples es ed. Fi e
cases
(16%) showed a diges ed
p oduc o 165 bp cha ac e is ic o he
G
o
A mu a ion.
Twen y cases (62%) showed an undiges ed
PCR
p o-
duc o 194 bp. In se en (22%) cases,
wo
agmen s
comig a ed in he aga ose gel, one
o
194 bp, and one
o 165 bp, co esponding o
a
mixed i al popula ion
(wild ype and mu an ). In hese cases, he possibili y
o pa ial diges ion wi h BSU 361 was uled ou by